Nomura Holdings
AEON icon

Nomura Holdings’s AEON Biopharma AEON Stock Holding History

Nomura Holdings’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,132
Closed -$2.26M – 1420
2022
Q4 		$2.26M Hold
3,132
– – 0.01% 682
2022
Q3 		$2.22M Hold
3,132
– – 0.01% 788
2022
Q2 		$2.21M Hold
3,132
– – 0.01% 779
2022
Q1 		$2.21M Buy
+3,132
New +$2.2M 0.01% 862

Other funds holding AEON

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCWM
Graham Capital Wealth Management Washington D.c., District of Columbia $113M AUM 11.26% 1-Year Est. Return

Nomura Holdings's AEON Position: Q1 2023 in Review

Nomura Holdings sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 3,132 shares — an estimated $2.26M sold.

Nomura Holdings first reported a position in AEON in Q1 2022 and held it in 4 quarters. The position peaked at $2.26M in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Nomura Holdings reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Nomura Holdings sold 3,132 AEON Biopharma shares in Q1 2023, an estimated $2.26M.
  • Nomura Holdings first reported a position in AEON Biopharma in Q1 2022 and held it in 4 quarters.
  • Nomura Holdings's AEON Biopharma position peaked at $2.26M in Q4 2022.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.